Hypereosinophilic Syndromes

Also known as: HES - Hypereosinophilic Syndrome / Hypereosinophilic Syndrome (HES) / Hyper Eosinophilic Syndrome / Hypereosinophilic Syndrome / Hypereosinophilic syndrome [HES], unspecified / Hypereosinophilic syndrome [HES] / Hypereosinophilic syndrome (morphologic abnormality) / Hypereosinophilic syndrome (disorder) / Idiopathic hypereosinophilic syndrome (morphologic abnormality) / Idiopathic hypereosinophilic syndrome (disorder) / Idiopathic Hypereosinophilic Syndrome

DrugDrug NameDrug Description
DB01005HydroxyureaAn antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip).
DB00619ImatinibA tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.
DB06612MepolizumabA fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.
DrugDrug NameTargetType
DB01005HydroxyureaRibonucleoside-diphosphate reductase large subunittarget
DB01005HydroxyureaSolute carrier organic anion transporter family member 1A2transporter
DB01005HydroxyureaSolute carrier organic anion transporter family member 1B1transporter
DB01005HydroxyureaSolute carrier organic anion transporter family member 1B3transporter
DB01005HydroxyureaUrea transporter 2transporter
DB01005HydroxyureaUrea transporter 1transporter
DB01005HydroxyureaSolute carrier family 22 member 4transporter
DB01005HydroxyureaSolute carrier family 22 member 5transporter
DB01005HydroxyureaSerum albumincarrier
DB01005HydroxyureaUrease subunit alphaenzyme
DB00619ImatinibPlatelet-derived growth factor receptor betatarget
DB00619ImatinibTyrosine-protein kinase ABL1target
DB00619ImatinibMast/stem cell growth factor receptor Kittarget
DB00619ImatinibProto-oncogene tyrosine-protein kinase receptor Rettarget
DB00619ImatinibHigh affinity nerve growth factor receptortarget
DB00619ImatinibMacrophage colony-stimulating factor 1 receptortarget
DB00619ImatinibPlatelet-derived growth factor receptor alphatarget
DB00619ImatinibEpithelial discoidin domain-containing receptor 1target
DB00619ImatinibCytochrome P450 3A4enzyme
DB00619ImatinibBreakpoint cluster region proteintarget
DB00619ImatinibCytochrome P450 1A2enzyme
DB00619ImatinibCytochrome P450 2D6enzyme
DB00619ImatinibCytochrome P450 2C9enzyme
DB00619ImatinibCytochrome P450 2C19enzyme
DB00619ImatinibCytochrome P450 3A5enzyme
DB00619ImatinibCytochrome P450 3A7enzyme
DB00619ImatinibSolute carrier family 22 member 1transporter
DB00619ImatinibP-glycoprotein 1transporter
DB00619ImatinibSolute carrier family 22 member 2transporter
DB00619ImatinibATP-binding cassette sub-family G member 2transporter
DB00619ImatinibATP-binding cassette sub-family A member 3transporter
DB00619ImatinibSerum albumincarrier
DB00619ImatinibAlpha-1-acid glycoprotein 1carrier
DB00619ImatinibBile salt export pumptransporter
DB00619ImatinibCytochrome P450 2C8enzyme
DB00619ImatinibCanalicular multispecific organic anion transporter 1transporter
DB00619ImatinibMultidrug resistance-associated protein 1transporter
DB00619ImatinibSolute carrier family 22 member 5transporter
DB00619ImatinibSolute carrier organic anion transporter family member 1B3transporter
DB00619ImatinibMultidrug resistance-associated protein 4transporter
DB00619ImatinibSolute carrier organic anion transporter family member 1A2transporter
DB00619ImatinibDiscoidin domain-containing receptor 2target
DB06612MepolizumabInterleukin-5target
DrugDrug NamePhaseStatusCount
DB06612Mepolizumab1 / 2Completed1
DB04868Nilotinib1 / 2Completed1
DB01254Dasatinib2Completed1
DB15130Dexpramipexole2Unknown Status1
DB00619Imatinib2Completed2
DB00619Imatinib2Recruiting1
DB00619Imatinib2Terminated2
DB00619Imatinib2Unknown Status1
DB06602Reslizumab2Completed1
DB08877Ruxolitinib2Recruiting2
DB12023Benralizumab3Recruiting1
DB06612Mepolizumab3Completed3
DB06612Mepolizumab3Recruiting1
DB06612Mepolizumab3Terminated1
DB00860Prednisolone3Completed1
DB00635Prednisone3Completed1
DB00635Prednisone4Completed1
DB00619ImatinibNot AvailableCompleted1
DB06612MepolizumabNot AvailableNo Longer Available1
DB04868NilotinibNot AvailableNo Longer Available1